| Date | Name | Title | Filing | Type | Shares Traded | Price Range | Total Held |
|---|---|---|---|---|---|---|---|
| May 16, 2014 | Director | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 15,500 | -- | -- | |
| Apr 14, 2014 | SVP, Business Development | Form 4 | Open market or private purchase of non-derivative or derivative security | 1,000 | $13.90 | 27,005 | |
| Apr 14, 2014 | Director | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 15,500 | $11.00 | 42,066 | |
| Jan 28, 2014 | SVP, GM - International | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 1,175 | $16.67 | 20,715 | |
| Jan 28, 2014 | SVP, GM - Oncology | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 357 | $16.67 | 26,888 | |
| Dec 20, 2013 | Director, President and CEO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 80,000 | -- | 154,290 | |
| Dec 17, 2013 | CTO and COO | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 163 | $15.63 | 17,855 | |
| Nov 15, 2013 | SVP, Business Development | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 1,392 | $15.62 | 23,158 | |
| Nov 14, 2013 | VP - Global Finance | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 4,373 | $13.18 | 27,501 | |
| Nov 14, 2013 | VP - Global Finance | Form 4 | Open market or private sale of non-derivative or derivative security | 4,373 | $15.46 | 23,128 |
For recent transactions, including derivative transactions, see our Section 16 SEC filings page.